Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Oncology|July 19, 2021
Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer PatientsYujie Lu, Yiwei Tong, Xiaosong Chen, et al.
Cancer Biomarkers : Section a of Disease Markers|August 1, 2022
Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patientsYufei Zeng, Weiqi Gao, Xiaosong Chen, et al.
Journal of Breast Cancer|May 21, 2024
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 PatientsLiangqiang Li, Jing Yu, Kunwei Shen, et al.
Frontiers in Oncology|August 8, 2022
Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patientsZhuoxuan Li, Yiwei Tong, Xiaosong Chen, et al.
Therapeutic Advances in Medical Oncology|May 31, 2023
Association of serum lipid levels and clinical outcomes in early breast cancer patientsShuwen Dong, Jing Yu, Xiaosong Chen, et al.
British Journal of Cancer|December 18, 2020
Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ componentYufei Zeng, Weiqi Gao, Xiaosong Chen, et al.
Frontiers in Cell and Developmental Biology|April 5, 2021
CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast CancerXi Sun, Zheng Wang, Xiaosong Chen, et al.
Frontiers in Oncology|April 12, 2021
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and PrognosisShuwen Dong, Zheng Wang, Kunwei Shen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer]Yuzi Zhang, Qing Qu, Yan Mao, et al.
Frontiers in Oncology|August 15, 2022
A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancerRenhong Huang, Liangqiang Li, Zheng Wang, et al.
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Oncology|July 19, 2021
Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer PatientsYujie Lu, Yiwei Tong, Xiaosong Chen, et al.
Cancer Biomarkers : Section a of Disease Markers|August 1, 2022
Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patientsYufei Zeng, Weiqi Gao, Xiaosong Chen, et al.
Journal of Breast Cancer|May 21, 2024
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 PatientsLiangqiang Li, Jing Yu, Kunwei Shen, et al.
Frontiers in Oncology|August 8, 2022
Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patientsZhuoxuan Li, Yiwei Tong, Xiaosong Chen, et al.
Therapeutic Advances in Medical Oncology|May 31, 2023
Association of serum lipid levels and clinical outcomes in early breast cancer patientsShuwen Dong, Jing Yu, Xiaosong Chen, et al.
British Journal of Cancer|December 18, 2020
Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ componentYufei Zeng, Weiqi Gao, Xiaosong Chen, et al.
Frontiers in Cell and Developmental Biology|April 5, 2021
CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast CancerXi Sun, Zheng Wang, Xiaosong Chen, et al.
Frontiers in Oncology|April 12, 2021
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and PrognosisShuwen Dong, Zheng Wang, Kunwei Shen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer]Yuzi Zhang, Qing Qu, Yan Mao, et al.
Frontiers in Oncology|August 15, 2022
A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancerRenhong Huang, Liangqiang Li, Zheng Wang, et al.
Pageof 21